STOCK TITAN

MiniMed Group (MMED) counsel reports 1,762-share tax withholding on RSU vesting

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

MiniMed Group, Inc. executive Courtney Nelson, SVP, General Counsel and Corporate Secretary, reported a tax-withholding disposition of 1,762 shares of common stock on July 31, 2026, at $18.15 per share. The shares were withheld to cover income taxes on vesting RSUs, leaving 136,384 shares held directly, including shares issuable from RSUs.

Positive

  • None.

Negative

  • None.
Insider Wills Courtney Nelson
Role SVP, Gen. Counsel, Corp. Sec.
Type Security Shares Price Value
Tax Withholding Common Stock F1, F2 1,762 $18.15 $32K
Holdings After Transaction: Common Stock — 136,384 shares (Direct)
Footnotes (2)
  1. F1. Represents shares of Common Stock that have been withheld by MiniMed Group, Inc. to satisfy income tax withholding and remittance obligations in connection with the vesting and net settlement of Restricted Stock Units ("RSUs").
  2. F2. Includes shares of Common Stock to be issued in connection with the vesting of one or more RSUs.
Shares withheld for taxes 1,762 shares Common Stock withheld to satisfy income tax obligations on RSU vesting
Per-share value for withholding $18.15 per share Value used for the 1,762 withheld shares in the tax-withholding disposition
Shares held after transaction 136,384 shares Direct holdings after withholding, including shares to be issued from RSUs
Tax-liability shares in this report 1,762 shares Shares associated with payment of tax liability by delivering or withholding securities
Restricted Stock Units ("RSUs") financial
"in connection with the vesting and net settlement of Restricted Stock Units ("RSUs")"
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
net settlement financial
"in connection with the vesting and net settlement of Restricted Stock Units"
income tax withholding and remittance obligations financial
"withheld by MiniMed Group, Inc. to satisfy income tax withholding and remittance obligations"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What transaction did MiniMed Group (MMED) insider Courtney Nelson report?

Courtney Nelson reported a tax-withholding disposition of 1,762 MiniMed (MMED) shares of common stock. The shares were withheld by the company to satisfy income tax obligations arising from the vesting and net settlement of Restricted Stock Units, rather than sold in an open-market trade.

At what price were the withheld MiniMed (MMED) shares valued in the transaction?

The 1,762 MiniMed (MMED) shares used for tax withholding were valued at $18.15 per share. This price is used solely for the tax-withholding calculation linked to the vesting RSUs and does not describe a market sale execution price.

How many MiniMed (MMED) shares does Courtney Nelson hold after this transaction?

After the tax-withholding event, Courtney Nelson is reported as holding 136,384 MiniMed (MMED) shares directly. This figure includes shares of common stock that will be issued in the future as one or more Restricted Stock Units vest.

What is the purpose of the 1,762 MiniMed (MMED) shares withheld in this report?

The 1,762 MiniMed (MMED) shares represent stock withheld by the company to satisfy income tax withholding and remittance obligations. This occurred in connection with the vesting and net settlement of Restricted Stock Units awarded to Courtney Nelson as part of equity compensation.

Does the MiniMed (MMED) report involve any derivative securities or options exercises?

No derivative securities are listed for this MiniMed (MMED) insider report. The transaction solely involves common stock withheld to cover tax liabilities tied to vesting Restricted Stock Units, with no reported option exercises or other derivative conversions in this disclosure.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Wills Courtney Nelson

(Last)(First)(Middle)
C/O MINIMED GROUP, INC.
18000 DEVONSHIRE STREET

(Street)
NORTHRIDGE CALIFORNIA 91325

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
MiniMed Group, Inc. [ MMED ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
SVP, Gen. Counsel, Corp. Sec.
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/31/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock07/31/2026F1,762(1)D$18.15136,384(2)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Represents shares of Common Stock that have been withheld by MiniMed Group, Inc. to satisfy income tax withholding and remittance obligations in connection with the vesting and net settlement of Restricted Stock Units ("RSUs").
2. Includes shares of Common Stock to be issued in connection with the vesting of one or more RSUs.
Remarks:
/s/ Bryan F. Kelly, attorney-in-fact08/04/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)